Array BioPharma Inc. (ARRY) |
|
46.505 -0.075 (-0.16%)
|
06-19 13:49 |
|
Open: |
46.6 |
Pre. Close: |
46.58 |
|
High:
|
46.74 |
Low:
|
46.49 |
|
Volume:
|
8,983,967 |
Market Cap:
|
10375M |
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
46.928 - 47.067 |
47.067 - 47.222 |
|
Low:
|
45.962 - 46.134 |
46.134 - 46.326 |
|
Close:
|
46.279 - 46.537 |
46.537 - 46.825 |
|
Technical analysis |
as of: 2019-06-19 1:24:58 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 54.95 One year: 64.19 |
| Support: |
Support1: 30.91  Support2: 20.93 |
| Resistance: |
Resistance1: 47.05 Resistance2: 54.95 |
| Pivot: |
32.18 |
| Moving Average: |
MA(5): 39.72 MA(20): 30.76
MA(100): 24.26 MA(250): 19.05 |
| MACD: |
MACD(12,26): 4.66 Signal(9): 2.67 |
| Stochastic oscillator: |
%K(14,3): 97.54 %D(3): 96.04 |
| RSI: |
RSI(14): 90.92 |
| 52-week: |
High: 47.05 Low: 12.56 Change(%): 133.1 |
| Average Vol(K): |
3-Month: 454129 10-Days: 1287735 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.ARRY has closed below upper band by 0.1%. Bollinger Bands are 528.5% wider than normal. The large width of the bands suggest high volatility as compared to ARRY's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Tue, 18 Jun 2019 15:35:17 Z
Company News For Jun 18, 2019
Tue, 18 Jun 2019 13:28:36 Z
ARRY Crosses Above Average Analyst Target
Tue, 18 Jun 2019 01:27:56 Z
Dow Jones Today: Almost a Case of the Mondays
Tue, 18 Jun 2019 00:28:21 Z
5 Top Stock Trades for Tuesday: FB, NFLX, GILD, TSLA
Mon, 17 Jun 2019 22:30:22 Z
Why Pfizer's Acquisition of Array BioPharma Won't Pay Off Anytime Soon
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
221.75 |
| Shares Float (M) |
218.52 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
|
|
Shares Short (K)
|
|
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-0.640 |
|
EPS Est. Current Year
|
-0.990 |
|
EPS Est. Next Year
|
-0.390 |
|
EPS Est. Next Quarter
|
-0.230 |
|
Forward EPS
|
-0.570 |
|
Book Value (p.s.)
|
21.160 |
|
PEG Ratio
|
-4.40 |
|
Profit Margin
|
|
|
Operating Margin
|
-61.32 |
|
Return on Assets (ttm)
|
-23.7 |
|
Return on Equity (ttm)
|
-44.5 |
|
Qtrly Rev. Growth
|
33.4 |
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-116.06 |
|
Levered Free Cash Flow (M)
|
-57.37 |
Stock Valuations |
|
P/E
|
-72.80 |
|
P/E Growth Ratio
|
|
|
P/BV
|
2.20 |
|
P/S
|
11479258112.00 |
|
P/CF
|
-89.02 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
